July 17, 2023
Fempharma has been successfully audited for ISO 13485:2016 Manufacturing and Trade of Medical Devices by Tequa-Zert, a TÜV Hessen partner.
UPCOMING EVENTS
CPHI Milan, October 6-8, 2026, Milan, Italy
We are excited to exhibit this year’s CPHI, one of the world’s largest pharma event, taking place on October 6-8, 2026 in Milan, Italy.
You can meet us and discover our innovative product portfolio in Hall 08 at our Booth 8S39.
CPhI Franfurt, November 9-11, 2027, Frankfurt, Germany
We are excited to be present at 2027 CPhI, one of the world’s largest pharma event.
RECENT NEWS
-
-
June 25th, 2023
We have presented our latest study “A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle... Read More -
June 22, 2023
Our latest study about the efficacy of INCOXIL has been published at the BMC Women’s Health titled “A randomized controlled pilot trial to assess the... Read More -
May 21st, 2023
We have presented our latest study “A randomized controlled trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training... Read More -
May 19th, 2023
New clinical trial for Juvia has started. Vaginitis is one of the most common gynecological problems in women. Candida albicans is responsible for more than... Read More -
May 4th, 2023
Fempharma’s proprietary vaginal moisturizer gel JUVIA has gotten into the shelves at Rossmann Hungary. -
April 19th, 2023
Fempharma has been successfully audited for ISO 22000:2018 research and development, contract manufacturing of dietary supplements.